Neurotoxin Research Group, School of Medical & Molecular Biosciences, University of Technology, Sydney, PO Box 123, Broadway, NSW 2007, Australia.
Toxicon. 2011 Oct;58(5):439-52. doi: 10.1016/j.toxicon.2011.08.003. Epub 2011 Aug 10.
The venom of the Australian lowlands copperhead, Austrelaps superbus, produces significant and potentially lethal neurotoxic paralysis in cases of clinical envenomation. However, little is known about the neurotoxic components within this venom or venoms from the related alpine copperhead (Austrelaps ramsayi) or pygmy copperhead (Austrelaps labialis). Using the isolated chick biventer cervicis nerve-muscle preparation, all Austrelaps venoms were found to exhibit potent and rapid inhibition of nerve-evoked twitch contractions and block of contractures to nicotinic agonists, consistent with postsynaptic neurotoxic activity. Following separation by size-exclusion liquid chromatography under non-denaturing conditions, all Austrelaps venoms were found to also contain a high molecular mass fraction with only weak phospholipase A(2) (PLA(2)) activity that caused a slow inhibition of twitch contractions, without inhibiting contractures to nicotinic agonists. These actions are consistent with the presence of additional snake presynaptic PLA(2) neurotoxin (SPAN) complexes in all three Austrelaps venoms. However, there was no evidence of direct muscle damage produced by any Austrelaps venom or SPAN complex. Monovalent tiger snake antivenom was effective in neutralising the neurotoxicity of both whole venom and the SPAN complex. However antivenom was unable to effectively reverse whole venom neurotoxicity, or prejunctional SPAN neurotoxicity, once established. Given the strong neurotoxicity of all Austrelaps venoms, particularly A. ramsayi and A. labialis, effective bites from these copperhead species should be considered potentially lethal. Furthermore, clinicians need to be aware of possible irreversible presynaptic neurotoxicity following envenomation from all copperhead species and that early antivenom intervention is important in preventing further development of toxicity.
澳大利亚低地铜头蛇的毒液在临床蛇伤的情况下会产生显著的、潜在致命的神经毒性瘫痪。然而,对于这种毒液或相关高山铜头蛇(Austrelaps ramsayi)或小铜头蛇(Austrelaps labialis)的毒液中的神经毒性成分知之甚少。使用分离的鸡双颈椎神经-肌肉制备物,发现所有 Austrelaps 毒液都表现出强烈而快速的抑制神经诱发的抽搐收缩和对烟碱激动剂的收缩阻断,与突触后神经毒性活性一致。在非变性条件下通过大小排阻液相色谱分离后,发现所有 Austrelaps 毒液都还含有一个高分子质量分数,只有微弱的磷脂酶 A(2)(PLA(2))活性,可引起抽搐收缩缓慢抑制,而不抑制烟碱激动剂的收缩。这些作用与所有三种 Austrelaps 毒液中存在额外的蛇突触前 PLA(2)神经毒素(SPAN)复合物一致。然而,没有证据表明任何 Austrelaps 毒液或 SPAN 复合物会直接导致肌肉损伤。单价虎蛇抗蛇毒血清能有效中和全毒液和 SPAN 复合物的神经毒性。然而,抗蛇毒血清一旦建立,就无法有效逆转全毒液的神经毒性或突触前 SPAN 神经毒性。鉴于所有 Austrelaps 毒液的强烈神经毒性,特别是 A. ramsayi 和 A. labialis,来自这些铜头蛇种的有效咬伤应被视为潜在致命的。此外,临床医生需要意识到所有铜头蛇种蛇伤后可能存在不可逆转的突触前神经毒性,早期使用抗蛇毒血清干预对于防止毒性进一步发展非常重要。